NCT02922660

Brief Summary

This is a single-center, randomized, prospective research which aims to investigate the advantages and disadvantages between desflurane balanced anesthesia and TIVA-TCI with propofol in ophthalmic ambulatory surgery, so that to evaluate a better anesthesia method in ophthalmic surgery through a large sample clinical study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
209

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2016

Completed
3 days until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 4, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

January 23, 2018

Status Verified

January 1, 2018

Enrollment Period

1.2 years

First QC Date

September 28, 2016

Last Update Submit

January 21, 2018

Conditions

Keywords

Ambulatory surgeryOphthalmicInhalation anesthesiaDesfluraneTotal intravenous anesthesia

Outcome Measures

Primary Outcomes (1)

  • Awake time

    "Anesthesia ends" means stop infusing or inhaling any anaesthetic.

    From the ending time of anesthesia until the recovery time of patient's consciousness, assessed up to half an hour postoperatively.

Secondary Outcomes (7)

  • Discharge time

    From the ending time of anesthesia until the time of extubation, assessed up to half an hour postoperatively.

  • Stay time in the postoperative care unit

    Measuring the stay time in postoperative care unit, assessed up to one hour postoperatively.

  • Quality of recovery in 1 day postoperatively

    Start scaling when 1 day(24 hour) postoperatively.

  • Incidences in postoperative nausea and vomiting(PONV)

    Start scaling in 1 day(24 hour) postoperatively.

  • Incidences in postoperative agitation

    Start scaling in 1 day(24 hour) postoperatively.

  • +2 more secondary outcomes

Study Arms (2)

Group TIVA

EXPERIMENTAL

method of anesthesia is total intravenous anesthesia(TIVA) and maintenance with propofol Cp 2-4 μg/ml and remifentanil 2-4 ng/ml in target controlled infusion(TCI) during the procedure

Procedure: total intravenous anesthesiaDrug: PropofolDrug: Remifentanil

Group Des

EXPERIMENTAL

method of anesthesia is inhalation anesthesia and maintenance with desflurane ranged from 0.5\~1.5 MAC during the procedure

Drug: desfluraneProcedure: inhalation anesthesia

Interventions

method of anesthesia maintenance with desflurane ranged from 0.5\~1.5 MAC during the procedure

Also known as: Ethane,2--1,1,1,2-tetrafluoro
Group Des

method of anesthesia in group TIVA is total intravenous anesthesia(TIVA) during the procedure

Also known as: TIVA
Group TIVA

method of anesthesia in group DES is inhalation anesthesia with desflurane during the procedure

Group Des

using propofol as sedative during the procedure of anesthesia and maintaining with propofol Cp 2-4 μg/ml in TCI

Also known as: Disoprofol
Group TIVA

using remifentanil as analgesics during the procedure of anesthesia and maintaining with remifentanil 2-4 ng/ml in TCI

Also known as: Remifentanil Hydrochloride for Injection
Group TIVA

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years patients undergoing selective ophthalmic ambulatory surgery;
  • ASA I and II
  • duration of anesthesia at least 30min
  • without apparent organ comorbidities
  • sign the informed consent form

You may not qualify if:

  • equal or greater than ASA III
  • has a history of dementia,psychiatric disorders or central nervous system diseases
  • taking sedatives, antidepressant or glucocorticoid
  • without family members
  • has cardiac, respiratory,liver,kidney comorbidities
  • uncontrolled hypertension(\>180/100mmHg)
  • laryngeal mask fail to insert, and change to tracheal intubation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan ophthalmic center, Sun Yat-sen University

Guangzhou, Guangdong, 510080, China

Location

Related Publications (10)

  • Aylin P, Williams S, Jarman B, Bottle A. Trends in day surgery rates. BMJ. 2005 Oct 8;331(7520):803. doi: 10.1136/bmj.331.7520.803. No abstract available.

    PMID: 16210281BACKGROUND
  • Neel ST. Effect of Conversion to Immediate Sequential Cataract Surgery on Ambulatory Surgery Centers in the United States in the Cost-Analysis Model. JAMA Ophthalmol. 2015 Jul;133(7):856-7. doi: 10.1001/jamaophthalmol.2015.0941. No abstract available.

    PMID: 25906175BACKGROUND
  • Chen CH, Yang YL, Chen WM, Shyr MH. Comparison of the anesthesia profiles between sevoflurane-nitrous oxide and propofol-nitrous oxide conveyed by laryngeal mask airway in patients undergoing ambulatory gynecological surgery. Acta Anaesthesiol Taiwan. 2006 Jun;44(2):101-7.

    PMID: 16845915BACKGROUND
  • Kumar G, Stendall C, Mistry R, Gurusamy K, Walker D. A comparison of total intravenous anaesthesia using propofol with sevoflurane or desflurane in ambulatory surgery: systematic review and meta-analysis. Anaesthesia. 2014 Oct;69(10):1138-50. doi: 10.1111/anae.12713. Epub 2014 May 22.

    PMID: 24847783BACKGROUND
  • Coskun D, Celebi H, Karaca G, Karabiyik L. Remifentanil versus fentanyl compared in a target-controlled infusion of propofol anesthesia: quality of anesthesia and recovery profile. J Anesth. 2010 Jun;24(3):373-9. doi: 10.1007/s00540-010-0898-1. Epub 2010 Mar 13.

    PMID: 20229001BACKGROUND
  • Majholm B, Bartholdy J, Clausen HV, Virkus RA, Engbaek J, Moller AM. Comparison between local anaesthesia with remifentanil and total intravenous anaesthesia for operative hysteroscopic procedures in day surgery. Br J Anaesth. 2012 Feb;108(2):245-53. doi: 10.1093/bja/aer337. Epub 2011 Nov 23.

    PMID: 22113931BACKGROUND
  • Eikaas H, Raeder J. Total intravenous anaesthesia techniques for ambulatory surgery. Curr Opin Anaesthesiol. 2009 Dec;22(6):725-9. doi: 10.1097/ACO.0b013e3283310f6b.

    PMID: 19680121BACKGROUND
  • Yoo YC, Bai SJ, Lee KY, Shin S, Choi EK, Lee JW. Total intravenous anesthesia with propofol reduces postoperative nausea and vomiting in patients undergoing robot-assisted laparoscopic radical prostatectomy: a prospective randomized trial. Yonsei Med J. 2012 Nov 1;53(6):1197-202. doi: 10.3349/ymj.2012.53.6.1197.

    PMID: 23074122BACKGROUND
  • Rinehardt EK, Sivarajan M. Costs and wastes in anesthesia care. Curr Opin Anaesthesiol. 2012 Apr;25(2):221-5. doi: 10.1097/ACO.0b013e32834f00ec.

    PMID: 22157199BACKGROUND
  • Zhu YL, Shen WH, Chen QR, Ye HJ, Huang JX, Kang Y, Chi W, Gan XL. Desflurane anesthesia compared with total intravenous anesthesia on anesthesia-controlled operating room time in ambulatory surgery following strabotomy: a randomized controlled study. Chin Med J (Engl). 2020 Apr 5;133(7):779-785. doi: 10.1097/CM9.0000000000000728.

MeSH Terms

Interventions

DesfluraneAnesthesia, InhalationPropofolRemifentanilInjections

Intervention Hierarchy (Ancestors)

Ethyl EthersEthersOrganic ChemicalsMethyl EthersHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbonsAnesthesia, GeneralAnesthesiaAnesthesia and AnalgesiaPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicPropionatesAcids, AcyclicCarboxylic AcidsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsDrug Administration RoutesDrug TherapyTherapeutics

Study Officials

  • Yizhi Liu

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
associate chief physician

Study Record Dates

First Submitted

September 28, 2016

First Posted

October 4, 2016

Study Start

October 1, 2016

Primary Completion

December 1, 2017

Study Completion

January 1, 2018

Last Updated

January 23, 2018

Record last verified: 2018-01

Locations